{
  "ok": true,
  "listing": {
    "id": "lst_01M1RFRE1HM8J2GX2VW2RC1V9R",
    "slug": "international-myeloma-foundation",
    "businessName": "International Myeloma Foundation",
    "legalName": "",
    "description": {
      "short": "In this week's video, Dr. Brian G.M. Durie discusses what patients and caregivers need to know about the approval of elotuzumab (Empliciti).",
      "full": "In this week's video, Dr. Brian G.M. Durie discusses what patients and caregivers need to know about the approval of elotuzumab (Empliciti)."
    },
    "industry": "IMF",
    "website": "https://myeloma.org/",
    "rootDomain": "myeloma.org",
    "listingOrigin": "discovered",
    "entityType": "business",
    "entitySubtype": "commercial_organization",
    "entityClassification": {
      "type": "business",
      "subtype": "commercial_organization",
      "confidenceScore": 73,
      "classifiedAt": "2026-09-05T09:52:52.304Z",
      "government": null
    },
    "placementType": "country",
    "location": {
      "placementType": "country",
      "countryCode": "US",
      "countryName": "USA",
      "flag": "🇺🇸",
      "region": "CA",
      "city": "North Hollywood",
      "mode": "online"
    },
    "primaryCategory": null,
    "claimStatus": "unclaimed",
    "verificationStatus": "unverified",
    "verified": false,
    "businessVerification": {
      "applicable": true,
      "status": "pending_authority",
      "level": "none",
      "label": "Not Registry Verified",
      "badgeColor": "neutral",
      "countsAsVerified": false,
      "authority": "BankFind Suite",
      "registryId": null,
      "matchScore": 0,
      "authorityCode": "RA000744",
      "lei": null,
      "jurisdiction": "US",
      "registeredLegalName": null,
      "registryStatus": null,
      "registryUrl": null,
      "checkedAt": "2026-10-09T11:51:43.861Z",
      "verifiedAt": null,
      "nextCheckAt": "2026-10-10T00:31:30.840Z"
    },
    "businessVerified": false,
    "commercialStatus": "free",
    "agentStatus": "active",
    "paidProfile": false,
    "freshnessStatus": "current",
    "media": {
      "logo": "https://s3.us-west-1.wasabisys.com/imf-d8-prod/images/imf_logo2018_rgb.png",
      "explicitLogo": "https://s3.us-west-1.wasabisys.com/imf-d8-prod/images/imf_logo2018_rgb.png",
      "favicon": "https://s3.us-west-1.wasabisys.com/imf-d8-prod/images/favicon.jpg",
      "fallback": "https://myeloma.org/favicon.ico"
    },
    "scores": {
      "dataConfidence": 93,
      "quality": 90,
      "verification": 0
    },
    "qualityScore": 90,
    "urls": {
      "directory": "https://directory.websdocs.com/business/international-myeloma-foundation",
      "json": "https://directory.websdocs.com/business/international-myeloma-foundation.json",
      "website": "https://myeloma.org/",
      "gateway": null,
      "businessLlms": "https://directory.websdocs.com/business/international-myeloma-foundation/llms.txt",
      "businessSchema": "https://directory.websdocs.com/business/international-myeloma-foundation/schema.jsonld",
      "directorySitemap": "https://directory.websdocs.com/sitemap.xml",
      "directoryManifest": "https://directory.websdocs.com/.well-known/asg-directory.json",
      "directoryOpenApi": "https://directory.websdocs.com/api/openapi.json"
    },
    "publishedAt": "2026-09-05T09:52:52.950Z",
    "updatedAt": "2026-09-22T14:50:16.551Z",
    "offers": [],
    "promotions": [],
    "publications": [],
    "faq": [],
    "publicCollectionsMeta": {
      "offers": {
        "total": 0,
        "returned": 0,
        "truncated": false
      },
      "promotions": {
        "total": 0,
        "returned": 0,
        "truncated": false
      },
      "publications": {
        "total": 0,
        "returned": 0,
        "truncated": false
      },
      "faq": {
        "total": 0,
        "returned": 0,
        "truncated": false
      }
    },
    "locations": [],
    "businessDetailsAvailable": true,
    "businessNature": {
      "version": 1,
      "primary": "",
      "secondary": [],
      "customerMarkets": [],
      "otherLabel": "",
      "primaryLabel": "",
      "secondaryLabels": [],
      "provenance": {
        "sourceType": "",
        "sourceUrl": "",
        "updatedAt": null,
        "manuallyConfirmed": false
      }
    },
    "operatingHours": {
      "version": 1,
      "schedules": [],
      "provenance": {
        "sourceType": "",
        "sourceUrl": "",
        "updatedAt": null,
        "manuallyConfirmed": false
      }
    },
    "organizationType": "organization",
    "language": {
      "primary": "en",
      "supported": [
        "en"
      ],
      "currencies": []
    },
    "categories": [
      {
        "slug": "nonprofits-associations",
        "name": "Nonprofits & Associations",
        "primary": true,
        "confidenceScore": 61
      }
    ],
    "services": [],
    "products": [],
    "agentCapabilities": [
      {
        "key": "booking",
        "name": "Online booking",
        "description": "Detected from public website navigation or discovery metadata.",
        "protocol": "http",
        "actionUrl": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/3002&t=What%20should%20we%20know%20about%20FDA%20approval%20of%20elotuzumab?",
        "method": "GET",
        "authenticationRequired": false
      },
      {
        "key": "support",
        "name": "Online support",
        "description": "Detected from public website navigation or discovery metadata.",
        "protocol": "http",
        "actionUrl": "https://www.myeloma.org/patient-caregiver-information",
        "method": "GET",
        "authenticationRequired": false
      }
    ],
    "contacts": [
      {
        "type": "email",
        "label": "Public email",
        "value": "imfinfoline1@myeloma.org",
        "url": "https://mailto:imfinfoline1@myeloma.org/",
        "platform": "email",
        "primary": true,
        "verificationStatus": "public_source"
      },
      {
        "type": "phone",
        "label": "Public phone",
        "value": "+1-818-487-7455",
        "url": null,
        "platform": "phone",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "en",
        "value": "https://en.wikipedia.org/wiki/International_Myeloma_Foundation",
        "url": "https://en.wikipedia.org/wiki/International_Myeloma_Foundation",
        "platform": "en",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/myeloma",
        "url": "https://www.facebook.com/myeloma",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/events/3318014685044422",
        "url": "https://www.facebook.com/events/3318014685044422",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/3002&t=What%20should%20we%20know%20about%20FDA%20approval%20of%20elotuzumab?",
        "url": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/3002&t=What%20should%20we%20know%20about%20FDA%20approval%20of%20elotuzumab?",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/1096&t=About%20Us",
        "url": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/1096&t=About%20Us",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/976&t=International%20Myeloma%20Foundation",
        "url": "https://www.facebook.com/sharer.php?u=https://www.myeloma.org/node/976&t=International%20Myeloma%20Foundation",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "facebook",
        "value": "https://www.facebook.com/events/1388778123259596",
        "url": "https://www.facebook.com/events/1388778123259596",
        "platform": "facebook",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "instagram",
        "value": "https://www.instagram.com/imfmyeloma",
        "url": "https://www.instagram.com/imfmyeloma",
        "platform": "instagram",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "linkedin",
        "value": "https://www.linkedin.com/company/international-myeloma-foundation",
        "url": "https://www.linkedin.com/company/international-myeloma-foundation",
        "platform": "linkedin",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "linkedin",
        "value": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F3002&title=What+should+we+know+about+FDA+approval+of+elotuzumab%3F",
        "url": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F3002&title=What+should+we+know+about+FDA+approval+of+elotuzumab%3F",
        "platform": "linkedin",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "linkedin",
        "value": "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.myeloma.org%2Fnode%2F3002&title=What+should+we+know+about+FDA+approval+of+elotuzumab%3F",
        "url": "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.myeloma.org%2Fnode%2F3002&title=What+should+we+know+about+FDA+approval+of+elotuzumab%3F",
        "platform": "linkedin",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "linkedin",
        "value": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F1096&title=About+Us",
        "url": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F1096&title=About+Us",
        "platform": "linkedin",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "linkedin",
        "value": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F976&title=International+Myeloma+Foundation",
        "url": "https://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.myeloma.org%2Fnode%2F976&title=International+Myeloma+Foundation",
        "platform": "linkedin",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "twitter",
        "value": "https://www.twitter.com/",
        "url": "https://www.twitter.com/",
        "platform": "twitter",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "twitter",
        "value": "https://twitter.com/imfmyeloma",
        "url": "https://twitter.com/imfmyeloma",
        "platform": "twitter",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "twitter",
        "value": "https://twitter.com/share?url=https://www.myeloma.org/node/3002&text=What%20should%20we%20know%20about%20FDA%20approval%20of%20elotuzumab?&via=IMFmyeloma",
        "url": "https://twitter.com/share?url=https://www.myeloma.org/node/3002&text=What%20should%20we%20know%20about%20FDA%20approval%20of%20elotuzumab?&via=IMFmyeloma",
        "platform": "twitter",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "twitter",
        "value": "https://twitter.com/share?url=https://www.myeloma.org/node/1096&text=About%20Us&via=IMFmyeloma",
        "url": "https://twitter.com/share?url=https://www.myeloma.org/node/1096&text=About%20Us&via=IMFmyeloma",
        "platform": "twitter",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "twitter",
        "value": "https://twitter.com/share?url=https://www.myeloma.org/node/976&text=International%20Myeloma%20Foundation&via=IMFmyeloma",
        "url": "https://twitter.com/share?url=https://www.myeloma.org/node/976&text=International%20Myeloma%20Foundation&via=IMFmyeloma",
        "platform": "twitter",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "x",
        "value": "https://x.com/",
        "url": "https://x.com/",
        "platform": "x",
        "primary": false,
        "verificationStatus": "public_source"
      },
      {
        "type": "social",
        "label": "youtube",
        "value": "https://www.youtube.com/user/IMFMyeloma",
        "url": "https://www.youtube.com/user/IMFMyeloma",
        "platform": "youtube",
        "primary": false,
        "verificationStatus": "public_source"
      }
    ],
    "serviceAreas": [
      {
        "type": "online",
        "countryCode": "US",
        "region": "CA",
        "city": "North Hollywood",
        "postalCode": "91607",
        "radiusKm": null,
        "description": "North Hollywood, CA, US",
        "primary": true
      }
    ],
    "sources": [
      {
        "type": "website",
        "url": "https://www.myeloma.org/videos/should-we-know-about-fda-approval-elotuzumab",
        "title": "Elotuzumab | Int'l Myeloma Foundation",
        "primary": true,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/",
        "title": "Find Multiple Myeloma Information & Support | IMF",
        "primary": true,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/videos/imf-virtual-myeloma-community-workshop-mcw",
        "title": "IMF Virtual Myeloma Community Workshop (MCW): Focus on Newly Diagnosed Myeloma",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/resources-support/imf-support-network/myeloma-community-workshops",
        "title": "Multiple Myeloma Community Workshops | int Myeloma Fn",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/contact-black-swan-research",
        "title": "Contact Black Swan Research | The Int'l Myeloma Foundation",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/about-us/media-resources",
        "title": "Media Resources | The International Myeloma Foundation",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/about-us/affiliates",
        "title": "Our Affiliates and International Partners | IMF",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/about-imf",
        "title": "Multiple Myeloma Charity | International Myeloma Foundation",
        "primary": false,
        "lastObservedAt": "2026-09-22T13:53:24.466Z"
      },
      {
        "type": "website",
        "url": "https://www.myeloma.org/infoline",
        "title": "Call the Multiple Myeloma Cancer Hotline | IMF InfoLine",
        "primary": false,
        "lastObservedAt": "2026-09-05T09:52:42.058Z"
      }
    ],
    "timestamps": {
      "firstDiscoveredAt": "2026-09-05T09:52:42.058Z",
      "lastCrawledAt": "2026-09-22T13:53:37.774Z",
      "lastVerifiedAt": null,
      "publishedAt": "2026-09-05T09:52:52.950Z",
      "updatedAt": "2026-09-22T14:50:16.551Z"
    },
    "gatewayDiscovery": {
      "status": "unmapped",
      "activeAgent": false,
      "urls": {},
      "capabilities": {
        "ask": false,
        "checkout": false
      },
      "checkedAt": null
    },
    "quoteRequest": {
      "available": false,
      "endpoint": null
    }
  },
  "canonicalUrl": "https://directory.websdocs.com/business/international-myeloma-foundation",
  "generatedAt": "2026-11-21T01:42:36.486Z"
}